Titelbild

In the News

2017-11-02 – Labiotech.eu

German Biotech Pockets €18M in its Series A to Propel Autoimmune Disease Candidate Forward

Topas Therapeutics received an extra €4M from Boehringer Ingelheim Venture Fund to help its autoimmune disease candidates accelerated through trials.

By Alex Dale

https://labiotech.eu/topas-autoimmune-diseases-fundraising/